SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009191
Filing Date
2018-11-09
Accepted
2018-11-09 17:02:20
Documents
43
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ahpa-20180930x10q.htm 10-Q 670413
2 EX-31.1 ahpa-20180930ex311f3b452.htm EX-31.1 15566
3 EX-31.2 ahpa-20180930ex31251a083.htm EX-31.2 15408
4 EX-32.1 ahpa-20180930ex32102a6e7.htm EX-32.1 8180
5 EX-32.2 ahpa-20180930ex3227f9839.htm EX-32.2 7863
  Complete submission text file 0001558370-18-009191.txt   3277855

Data Files

Seq Description Document Type Size
6 EX-101.INS ahpa-20180930.xml EX-101.INS 568917
7 EX-101.SCH ahpa-20180930.xsd EX-101.SCH 39969
8 EX-101.CAL ahpa-20180930_cal.xml EX-101.CAL 19823
9 EX-101.DEF ahpa-20180930_def.xml EX-101.DEF 157015
10 EX-101.LAB ahpa-20180930_lab.xml EX-101.LAB 270131
11 EX-101.PRE ahpa-20180930_pre.xml EX-101.PRE 230301
Mailing Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022
Business Address 65 EAST 55TH STREET 18TH FLOOR NEW YORK NY 10022 212 593-6900
Avista Healthcare Public Acquisition Corp. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 181173854
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1